LONG TERM SAFETY AND EFFICACY OF DARATUMUMAB RAPID INTRAVENOUS INFUSION (90 MINUTES) AFTER THE THIRD DOSE IN MULTIPLE MYELOMA PATIENTS

Authors :: Francesca Di Martino
Francesca Bacchiarri
Anna Sicuranza
Elisabetta Zappone
Cristiana Caffarelli
Donatella Raspadori
Bianca Mecacci
Monica Bocchia
Alessandro Gozzetti
Marzia Defina
Emanuele Cencini
Vincenzo Sammartano
Source :: Clinical Lymphoma Myeloma and Leukemia. 19:e147-e148
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Cancer Research
Oncology
business.industry
Anesthesia
medicine
Daratumumab
Hematology
Long term safety
medicine.disease
business
Multiple myeloma

Tools